This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vivus Announces 2012 Medical Societal Meeting Schedule For Qsymia (Phentermine And Topiramate Extended-Release) CIV

MOUNTAIN VIEW, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the Qsymia™ medical societal meeting schedule upcoming in 2012. The VIVUS presence and Qsymia awareness at these key meetings include scientific presentations, continuing medical education or CME support and/or promotional product theater.

"The Qsymia Fall schedule will build on the success from The Obesity Society (TOS) meeting recently held in San Antonio. The Qsymia launch coincided with TOS and the response from the attendees was positive.  Qsymia was featured in several presentations, and traffic through the exhibit booth was very high," stated Michael Miller, SVP and Chief Commercial Officer of VIVUS. "Healthcare provider education and awareness of Qsymia are areas of primary focus during this initial launch period. Our participation in these upcoming medical meetings will further this cause beyond the obesity specialists." 

Upcoming conference schedule:
Conference  Dates Location
Academy of Managed Care Pharmacies Oct. 3-5, 2012 Cincinnati
American College of Nurse Practitioners Oct. 3-7, 2012 Toronto
7 th Annual Obesity Summit
(Cleveland Clinic) Oct. 4-5, 2012 Cleveland
Osteopathic Medical Conference &
Exposition Oct 7-11, 2012 San Diego
Cardiometabolic Health Congress Oct. 10-13, 2012 Boston
American Academy of Family Physicians Oct. 16-20, 2012 Philadelphia
American Society of Bariatric Physicians Oct. 24-28, 2012 Orlando
Obesity Action Coalition Oct. 25-28, 2012 Dallas
American Heart Association Nov. 3-7, 2012 Los Angeles

Qsymia is available only through certified mail order pharmacies that are part of the Qsymia Home Delivery Network, including CVS Pharmacy and Walgreens.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs